News

Protein Sciences Corporation News

Web Site: http://www.proteinsciences.com
- Sanofi Pasteur Inc. 1000 Research Pkwy., Meriden, CT 06450 - 7159
Tel: (203) 686-0800 Fax: (203) 686-0268

Protein Sciences Corporation, founded in 1983, is a privately held vaccine company with headquarters in Meriden, Connecticut. PSC's mission is to save lives and improve health.

View all News Articles for Protein Sciences Corporation

Flublok� Influenza Vaccine is now Nationwide - The Pure Choice for Adults 18 and Older

September 21, 2015

Protein Sciences Corporation announced today that Flublok Influenza Vaccine, that was shown to provide better protection against the flu than a traditional flu vaccine in a recent clinical study, is now available nationwide. Not only does Flublok work well, it is the only flu vaccine that is free of all of the following undesirable ingredients: formaldehyde, antibiotics, gluten, gelatin, egg protein, latex, thimerosal and other preservatives. This makes it the pure choice for flu protection for adults 18 and older.

Getting Flublok has never been easier. National retailers Target and Walmart are offering Flublok. Flublok is also available in many regional supermarkets and independent pharmacies, including Mariano's and Roundy's in the Chicago area, Brookshire's in Texas, and Price Chopper in the Northeast. Passport Health Clinics will once again offer Flublok at its sites nationwide. Passport patients can even book their vaccines online.

"We are pleased to partner with leading pharmacies to greatly expand access to our vaccine," said Manon Cox, President and CEO of Protein Sciences Corporation. "Anyone over 18 years of age will be able to walk into Target, Mariano's, Roundy's or Brookshire's nationwide and receive Flublok. At other stores, people are encouraged to call the pharmacy in advance to make sure Flublok is in stock when they come in for vaccination. Nearly all insurance providers cover Flublok so most people can get Flublok free of charge."

Flublok has found special appeal among health conscious individuals that prefer its purity and its popularity is growing among people focused on better protection. In a recent clinical study of the quadrivalent version of Flublok in approximately 9,000 adults 50 years and older, Flublok recipients were 43% less likely to develop culture confirmed influenza than people who received a licensed quadrivalent egg-based influenza vaccine.

Click here for more information about Flublok and where to get it.

Member News is provided as a service of the Midstate Chamber of Commerce and is also featured in the monthly "Chamber News" newsletter mailed to members.

The “original publication date” of Member News articles posted on this web site reflects the date this article was added to the Chamber database and may not necessarily reflect the date such news events occurred.